ema semaglutide GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, Warns EMA warns: Sharp increase in

[3] [4] While burping and mild gastrointestinal symptoms are common with semaglutide, certain presentations warrant prompt medical evaluation

Choosing an injection time that fits your schedule and body can make a meaningful difference in managing those effects, and in how easy it is to stick with your routine long-term

For instance, it resulted in greater weight loss than liraglutide (another GLP-1 receptor agonist) and has been associated with weight loss levels comparable to those achieved through bariatric surgery

Research suggests it is less effective for weight loss, and it has never been approved for that purpose